Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2006
Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma
Julie G Izzo, Usha Malhotra, Tsung-Teh Wu, et al.
JCO Clinical Cancer Informatics
|
May 30, 2019
A Deep Learning-Based Decision Support Tool for Precision Risk Assessment of Breast Cancer
Tiancheng He, Mamta Puppala, Chika F Ezeana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2008
Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia
Linda S Elting, Charles Lu, Carmelita P Escalante, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2018
DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway
Liana Adam, F Anthony San Lucas, Richard Fowler, et al.
Cancer
|
September 9, 2015
Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy
Andrew J Bishop, Joe Ensor, Stacy L Moulder, et al.
Journal of the Anus, Rectum and Colon
|
August 1, 2024
Trial Protocol of a Phase II Study of mFOLFOXIRI after Metastasectomy in Patients with Oligometastatic Colorectal Cancer (FANTASTIC Study)
Kozo Kataoka, Takeshi Yamada, Kentaro Yamazaki, et al.
Journal of Hepatocellular Carcinoma
|
August 31, 2016
Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma
Armeen Mahvash, Ravi Murthy, Bruno C Odisio, et al.
Cancer Cell
|
February 12, 2015
14-3-3ζ turns TGF-β's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2
Jia Xu, Sunil Acharya, Ozgur Sahin, et al.
Oncotarget
|
August 20, 2016
Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin
Michael J Overman, Van Morris, Helen Moinova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2011
Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy
Phuong K Morrow, Gerburg M Wulf, Joe Ensor, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2006
Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma
Julie G Izzo, Usha Malhotra, Tsung-Teh Wu, et al.
JCO Clinical Cancer Informatics
|
May 30, 2019
A Deep Learning-Based Decision Support Tool for Precision Risk Assessment of Breast Cancer
Tiancheng He, Mamta Puppala, Chika F Ezeana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2008
Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia
Linda S Elting, Charles Lu, Carmelita P Escalante, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 25, 2018
DNA Sequencing of Small Bowel Adenocarcinomas Identifies Targetable Recurrent Mutations in the ERBB2 Signaling Pathway
Liana Adam, F Anthony San Lucas, Richard Fowler, et al.
Cancer
|
September 9, 2015
Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy
Andrew J Bishop, Joe Ensor, Stacy L Moulder, et al.
Journal of the Anus, Rectum and Colon
|
August 1, 2024
Trial Protocol of a Phase II Study of mFOLFOXIRI after Metastasectomy in Patients with Oligometastatic Colorectal Cancer (FANTASTIC Study)
Kozo Kataoka, Takeshi Yamada, Kentaro Yamazaki, et al.
Journal of Hepatocellular Carcinoma
|
August 31, 2016
Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma
Armeen Mahvash, Ravi Murthy, Bruno C Odisio, et al.
Cancer Cell
|
February 12, 2015
14-3-3ζ turns TGF-β's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2
Jia Xu, Sunil Acharya, Ozgur Sahin, et al.
Oncotarget
|
August 20, 2016
Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin
Michael J Overman, Van Morris, Helen Moinova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 7, 2011
Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy
Phuong K Morrow, Gerburg M Wulf, Joe Ensor, et al.
Page
of 8